BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21698783)

  • 21. An unusual case of malignant peritoneal effusion.
    Panigrahi C; Sethy M; Adhya AK
    Cytopathology; 2022 Jan; 33(1):141-144. PubMed ID: 34242452
    [No Abstract]   [Full Text] [Related]  

  • 22. Pleural effusion as an initial manifestation of multiple myeloma.
    Deshpande AH; Munshi MM
    Acta Cytol; 2000; 44(1):103-4. PubMed ID: 10667171
    [No Abstract]   [Full Text] [Related]  

  • 23. Myelomatous pleural effusion: a diagnostic challenge.
    Malhotra KP; Agrawal V; Prasad N
    Indian J Cancer; 2010; 47(3):351-2. PubMed ID: 20587921
    [No Abstract]   [Full Text] [Related]  

  • 24. Pleural effusion in multiple myeloma.
    Rodríguez JN; Pereira A; Martínez JC; Conde J; Pujol E
    Chest; 1994 Feb; 105(2):622-4. PubMed ID: 8306782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascitic fluid cytology in a previously healthy woman.
    Martínez-Girón R; Martínez-Torre S
    Cytopathology; 2020 Jan; 31(1):63-64. PubMed ID: 31038821
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of computerized morphometric analysis in diagnosis of effusion specimens.
    Arora B; Setia S; Rekhi B
    Diagn Cytopathol; 2006 Oct; 34(10):670-5. PubMed ID: 16955473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse.
    Martín-Moro F; Roncancio A; Benito A; Talavera M; Villarrubia J; Blanchard MJ
    Ann Hematol; 2020 Nov; 99(11):2705-2706. PubMed ID: 32458065
    [No Abstract]   [Full Text] [Related]  

  • 28. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid.
    Chang KJ; Albers CG; Nguyen P
    Am J Gastroenterol; 1995 Jan; 90(1):148-50. PubMed ID: 7801920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature.
    Davidson B; Abeler VM
    Diagn Cytopathol; 2005 May; 32(5):307-9. PubMed ID: 15830366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary and pleural manifestations of multiple myeloma].
    Schelle M; Schreiber C; Knolle J; Florschütz A; Kachel R; Schreiber J
    Pneumologie; 2006 Dec; 60(12):743-8. PubMed ID: 17163315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Signet-ring cells in the ascitic effusion from a cirrhotic patient].
    Medina Pérez M; Pérez Martín D; González Martín C; López Hidalgo J
    Rev Esp Enferm Dig; 1999 Sep; 91(9):654-5. PubMed ID: 10502716
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of immunocytochemical sensitivity between formalin-fixed and alcohol-fixed specimens reveals the diagnostic value of alcohol-fixed cytocentrifuged preparations in malignant effusion cytology.
    Ikeda K; Tate G; Suzuki T; Mitsuya T
    Am J Clin Pathol; 2011 Dec; 136(6):934-42. PubMed ID: 22095380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.
    Sher T; Miller KC; Lee K; Chanan-Khan A
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):328-30. PubMed ID: 19717386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of plasma cell morphology in multiple myeloma.
    Paule B; Quillard J; Bisson M; Kahn MF; Massias P
    Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.
    Varricchio S; Pagliuca F; Travaglino A; Gallo L; Villa MR; Mascolo M
    J Cutan Pathol; 2019 Aug; 46(8):619-622. PubMed ID: 31025408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological study of serous effusions with the aid of tumour markers.
    Ray K; Mittal S; Gupta H; Jain M
    J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgM multiple myeloma: more on a rare and heterogeneous disease.
    Cabrera Q; Chantepie S; Salaun V; Levaltier X; Troussard X; Macro M
    Am J Hematol; 2011 Aug; 86(8):717-8; author reply 718-9. PubMed ID: 21630314
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cytological variations observed in the malignant cells in body cavity fluids].
    Matsuda M
    Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
    [No Abstract]   [Full Text] [Related]  

  • 39. Ascites as a presenting feature of relapsed multiple myeloma. Report of a case diagnosed by aspiration cytology.
    Khoddami M; Esphehani FN; Aslani FS
    Acta Cytol; 1992; 36(3):325-8. PubMed ID: 1580115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.